Kuo CF, et al. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649–62.
Zobbe K, et al. Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study. Rheumatology. 2018;58(5):836–9.
Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–90.
Bursill D, et al. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Ann Rheum Dis. 2019;78(11):1592–600.
Richette P, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31–8.
Dalbeth N, et al. Gout. The Lancet. 2021;397(10287):1843–55.
Dalbeth N, Haskard DO. Mechanisms of inflammation in gout. Rheumatology. 2005;44(9):1090–6.
Article CAS PubMed Google Scholar
Fisher MC, et al. The unclosing premature mortality gap in gout: a general population-based study. Ann Rheum Dis. 2017;76(7):1289–94.
Weiss G, et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis. 1994;106(2):263–71.
Article CAS PubMed Google Scholar
Ahmad MI, Masood S, Furlanetto DM, Nicolaou S. Urate crystals; beyond joints. Mini Review. Front Med. 2021;8. https://doi.org/10.3389/fmed.2021.649505.
Ridker PM, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119–31.
Article CAS PubMed Google Scholar
Ebrahimi F, et al. Colchicine for the secondary prevention of cardiovascular events. Cochrane Database Syst Rev. 2023;8:14808. https://doi.org/10.1002/14651858.CD014808.
Ferguson LD, et al. Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol. 2024;6(3):e156–67.
Article CAS PubMed Google Scholar
Kuo C-F, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology. 2009;49(1):141–6.
Krishnan E, et al. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688–96.
Article CAS PubMed Google Scholar
Richette P, et al. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10(11):654–61.
Article CAS PubMed Google Scholar
Singh JA. When gout goes to the heart: does gout equal a cardiovascular disease risk factor? Ann Rheum Dis. 2015;74(4):631–4.
Article CAS PubMed Google Scholar
Borghi C, et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med. 2020;80:1–11.
Article CAS PubMed Google Scholar
Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3s):S11-s16.
Clarson L, et al. Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis. Eur J Prev Cardiol. 2020;22(3):335–43.
Anderson JL, Knowlton KU. Cardiovascular Events and Gout Flares. JAMA. 2022;328(5):425–6.
Cox P, et al. The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis. Rheumatol Int. 2021;41(7):1209–19.
Article PubMed PubMed Central Google Scholar
Levin MH, Lichtenstein L, Scott HW. Pathologic changes in gout; survey of eleven necropsied cases. Am J Pathol. 1956;32(5):871–95.
CAS PubMed PubMed Central Google Scholar
•• Klauser AS, et al. Dual-Energy Computed Tomography Detection of Cardiovascular Monosodium Urate Deposits in Patients With Gout. JAMA Cardiol. 2019;4(10):1019–28. (This study confirmes that CV MSU plaques measured by DECT are in accordance with detectable MSU cristals in CPLM)
Article PubMed PubMed Central Google Scholar
Park JJ, et al. Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study. BMJ Open. 2014;4(7):e005308.
Article PubMed PubMed Central Google Scholar
Patetsios P, et al. Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol. 2001;88(2):188–916, a6.
Article CAS PubMed Google Scholar
Pascual E, et al. Mechanisms of crystal formation in gout-a structural approach. Nat Rev Rheumatol. 2015;11(12):725–30.
Article CAS PubMed Google Scholar
Schwabl C, et al. Ultrasonography and dual-energy computed tomography: impact for the detection of gouty deposits. Ultrasonography. 2021;40(2):197–206.
Neogi T, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–98.
Article CAS PubMed Google Scholar
Klauser AS, et al. Gout of hand and wrist: the value of US as compared with DECT. Eur Radiol. 2018;28(10):4174–81.
Article PubMed PubMed Central Google Scholar
Bongartz T, et al. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2015;74(6):1072–7.
Article CAS PubMed Google Scholar
Johnson TRC, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol. 2007;17(6):1510–7.
Halpern EJ, Feuchtner GM, Klauser AS. Identification of Cardiovascular Monosodium Urate Crystal Deposition in Patients With Gout Using Dual-Energy Computed Tomography—Reply. JAMA Cardiology. 2020;5(4):486–7.
Kim SC, et al. Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome. BMC Rheumatol. 2018;2:17.
Article PubMed PubMed Central Google Scholar
Barazani SH, et al. Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World J Radiol. 2020;12(8):184–94.
Article PubMed PubMed Central Google Scholar
• Feuchtner GM, et al. Monosodium Urate Crystal Deposition in Coronary Artery Plaque by 128-Slice Dual-Energy Computed Tomography: An Ex Vivo Phantom and In Vivo Study. J Comput Assist Tomogr. 2021;45(6):856–62. (This study shows an ex vivo phantom study confirming MSU detetion by DECT down to a concentration of 15%.)
• Ren H, et al. Detection of monosodium urate depositions and atherosclerotic plaques in the cardiovascular system by dual-energy computed tomography. Heliyon. 2024;10(2):e24548. (This study repots the biggest cohort of cardiac DECT so far.)
Article CAS PubMed PubMed Central Google Scholar
• Pascart T, et al. Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study. Semin Arthritis Rheum. 2021;51(4):895–902. (The autors describe the DECT measurement in peripheral arteries.)
Article CAS PubMed Google Scholar
• Yokose C, Eide SE, Huber FA, et al. Frequently Encountered artifacts in the application of dual-energy CT to cardiovascular imaging for urate crystals in gout: a matched-control study. Arthritis Care Res. 2024. https://doi.org/10.1002/acr.25312.
• Klauser AS, Strobl S, Schwabl C, et al. Prevalence of monosodium urate (MSU) deposits in cadavers detected by dual-energy computed tomography (DECT). Diagnostics (Basel, Switzerland). 2022;12(5). https://doi.org/10.3390/diagnostics12051240.
•• Dalbeth N, et al. Vascular deposition of monosodium urate crystals in gout: analysis of cadaveric tissue by dual-energy computed tomography and compensated polarizing light microscopy. Arthritis Rheumatol. 2022;74(7):1295–6. (This study proofs DECT negative plaques do not contain MSU cristals in CPLM)
Article CAS PubMed Google Scholar
Held J, Schwabl C, Haschka D, et al. Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques. Rheumatology (Oxford, England). 2024. https://doi.org/10.1093/rheumatology/keae240.
Døssing A, et al. Dual-Energy Computed Tomography for Detection and Characterization of Monosodium Urate, Calcium Pyrophosphate, and Hydroxyapatite: A Phantom Study on Diagnostic Performance. Invest Radiol. 2021;56(7):417–24.
留言 (0)